:XIa

Yideng Liang1, Ivan Tarandovskiy1, Stepan S Surov1

  • 1Office of Tissues and Advanced Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA.

概括

动物血对人类血栓生成 (TG) 触发物的敏感性差异很大,这使得临床前药物试验结果直接转化为人体研究变得复杂. 触发度的优化对于准确的解释至关重要.